Grażyna Pulka

1.8k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Grażyna Pulka is a scholar working on Physiology, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Grażyna Pulka has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Immunology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Grażyna Pulka's work include Asthma and respiratory diseases (16 papers), Biosimilars and Bioanalytical Methods (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Grażyna Pulka is often cited by papers focused on Asthma and respiratory diseases (16 papers), Biosimilars and Bioanalytical Methods (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Grażyna Pulka collaborates with scholars based in Poland, United States and Germany. Grażyna Pulka's co-authors include Andreas Wollenberg, Kenji Kabashima, Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue, Ryosuke Mihara, Ryszard Galus, Takafumi Etoh, Jonathan Stewart and Hiroki Yoshida and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Grażyna Pulka

30 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

2017 414 citations Thomas Ruzicka, Jon M. Hanifin et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Grażyna Pulka

Since Specialization

Citations

This map shows the geographic impact of Grażyna Pulka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grażyna Pulka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grażyna Pulka more than expected).

Fields of papers citing papers by Grażyna Pulka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grażyna Pulka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grażyna Pulka. The network helps show where Grażyna Pulka may publish in the future.

Co-authorship network of co-authors of Grażyna Pulka

This figure shows the co-authorship network connecting the top 25 collaborators of Grażyna Pulka. A scholar is included among the top collaborators of Grażyna Pulka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grażyna Pulka. Grażyna Pulka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CT ‐ P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study 2025 ·Allergy ·Sarbjit S. Saini, Marcus Maurer, (unknown), (unknown), (unknown), (unknown), (unknown), Grażyna Pulka, Marta Chełmińska, Adam Reich, (unknown), (unknown), Su‐Young Kim, Sewon Lee, (unknown), Jong‐Ho Kim, Clive Grattan	10
2	Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study 2025 ·Clinical and Translational Allergy ·Clive Grattan, (unknown), (unknown), (unknown), (unknown), (unknown), Grażyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Yunju Bae, Su‐Young Kim, Sewon Lee, (unknown), (unknown), (unknown), Jong‐Ho Kim, Sarbjit S. Saini	0
3	Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study 2025 ·Expert Opinion on Biological Therapy ·Jacek C. Szepietowski, Adam Reich, Steven R. Feldman, Grażyna Pulka, (unknown), (unknown), (unknown), Airi Põder, Gursharan Singh, (unknown), Kuldeep Kumar, (unknown), (unknown), (unknown), Elena Wolff‐Holz	0
4	Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability 2025 ·Advances in Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), Matthew A. Hummel, (unknown), (unknown), (unknown), (unknown), Grażyna Pulka, E Holz	0
5	A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis 2024 ·Journal of the American Academy of Dermatology ·Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, Jan Brzezicki, (unknown), (unknown), Grażyna Pulka, (unknown), (unknown), (unknown), (unknown), (unknown), Min-Kyung Lee, Young Hee Rho	11
6	A randomized phase III study to compare efficacy and safety of BAT2206 (proposed ustekinumab biosimilar) with reference ustekinumab in patients with moderate to severe plaque psoriasis 2024 ·Journal of the American Academy of Dermatology ·Xiao‐Yong Man, (unknown), Grażyna Pulka, Agnieszka Żebrowska, Yunhua Deng, (unknown), (unknown), Yunpeng Qi, (unknown), Qingfeng Dong, Min Zheng	1
7	Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study 2021 ·BioDrugs ·Steven R. Feldman, (unknown), Grażyna Pulka, Külli Kingo, (unknown), Fausto Berti, (unknown), (unknown), Eric Guenzi, (unknown), (unknown), Richard Kay, (unknown)	22
8	Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus 2019 ·Journal of Allergy and Clinical Immunology ·Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka, Yves Poulin, Jean‐David Bouaziz, Andreas Wollenberg, Dédée F. Murrell, Andrew Alexis, (unknown), Faiz Ahmad, Christophe Piketty, Alan Clucas	184
9	Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study 2018 ·Journal of Allergy and Clinical Immunology ·Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, Grażyna Pulka, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, (unknown), Thomas Ruzicka	176
10	Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study 2018 ·European Journal of Pharmaceutical Sciences ·Isaac Melamed, Michael Borte, (unknown), (unknown), Roger H. Kobayashi, Alan P. Knutsen, Sudhir Gupta, William Smits, Anna Pituch‐Noworolska, (unknown), Grażyna Pulka, Hans D. Ochs, James N. Moy	16
11	Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood 2017 ·Inflammation ·Stanisława Bazan‐Socha, Lucyna Mastalerz, (unknown), Lech Zaręba, Romy Kremers, Michał Ząbczyk, Grażyna Pulka, Teresa Iwaniec, H.C. Hemker, (unknown)	34
12	Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis breakdown → 2017 ·New England Journal of Medicine ·Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue, Grażyna Pulka, (unknown), Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida, Jonathan Stewart, Kenji Kabashima	414
13	Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study 2017 ·Journal of Clinical Immunology ·Michael Borte, Isaac Melamed, Grażyna Pulka, (unknown), Alan P. Knutsen, Hans D. Ochs, Roger H. Kobayashi, Ai Kobayashi, Sudhir Gupta, (unknown), William Smits, Anna Pituch‐Noworolska, James N. Moy	10
14	005 Humanized anti-interleukin-31 receptor A antibody nemolizumab (CIM331) suppresses pruritus and improves eczema in patients with moderate-to-severe atopic dermatitis 2016 ·Journal of Investigative Dermatology ·Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, Grażyna Pulka, (unknown), Andreas Wollenberg, Ryszard Galus, Ryosuke Mihara, (unknown), Thomas Ruzicka	6
15	Evaluation of the Quality of Life in Subjects with a History of Severe Anaphylactic Reaction to the Hymenoptera Venom 2015 ·Advances in respiratory medicine ·Natalia Nowak, Stanisława Bazan‐Socha, Grażyna Pulka, (unknown), (unknown)	12
16	Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler 2011 ·Respiratory Medicine ·Anna Bodzenta‐Łukaszyk, Grażyna Pulka, Andrzej Dymek, Dragoș Bumbăcea, Tammy McIver, (unknown), Heikki Mansikka	55
17	Dyspnea is Related to Family Functioning in Adult Asthmatics 2009 ·Journal of Asthma ·(unknown), Roman Nowobilski, Grażyna Pulka, (unknown), (unknown), Ewa Niżankowska‐Mogilnicka, Andrzej Szczeklik	8
18	The Use of Endobronchial Ultrasonography in Assessment of Bronchial Wall Remodeling in Patients With Asthma 2009 ·CHEST Journal ·Jerzy Soja, (unknown), Krzysztof Sładek, Krzysztof Okoń, Adam Ćmiel, (unknown), (unknown), Grażyna Pulka, (unknown), Ewa Niżankowska‐Mogilnicka, Andrzej Szczeklik	38
19	High-Resolution Computed Tomography Evaluation of Peripheral Airways in Asthma Patients: Comparison of Focal and Diffuse Air Trapping 2008 ·Respiration ·(unknown), (unknown), Krzysztof Sładek, Grażyna Pulka, Grażyna Bochenek, Jerzy Soja, Ewa Niżankowska‐Mogilnicka, Andrzej Szczeklik	12
20	Increased expression of collagen receptors: α₁β₁ and α₂β₁ integrins on blood eosinophils in bronchial asthma 2006 ·Clinical & Experimental Allergy ·Stanisława Bazan‐Socha, (unknown), Grażyna Pulka, (unknown), J. Musial	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact